ENZO BIOCHEM INC Quarterly Net Income (Loss) Attributable to Parent in USD from Q3 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Enzo Biochem Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2010 to Q3 2024.
  • Enzo Biochem Inc Net Income (Loss) Attributable to Parent for the quarter ending October 31, 2024 was -$3.38M, a 49% increase year-over-year.
  • Enzo Biochem Inc Net Income (Loss) Attributable to Parent for the twelve months ending October 31, 2024 was -$22.8M, a 194% decline year-over-year.
  • Enzo Biochem Inc annual Net Income (Loss) Attributable to Parent for 2024 was -$26.1M, a 229% decline from 2023.
  • Enzo Biochem Inc annual Net Income (Loss) Attributable to Parent for 2023 was $20.3M.
  • Enzo Biochem Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$18.3M, a 332% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$22.8M -$3.38M +$3.24M +49% Aug 1, 2024 Oct 31, 2024 10-Q 2024-12-16
Q2 2024 -$26.1M -$13.4M -$70.8M -123% May 1, 2024 Jul 31, 2024 10-K 2024-10-29
Q1 2024 $44.7M -$3.02M +$12.2M +80.1% Feb 1, 2024 Apr 30, 2024 10-Q 2024-06-13
Q4 2023 $32.6M -$3.06M +$8.26M +73% Nov 1, 2023 Jan 31, 2024 10-Q 2024-03-13
Q3 2023 $24.3M -$6.62M +$4.02M +37.8% Aug 1, 2023 Oct 31, 2023 10-Q 2024-12-16
Q2 2023 $20.3M $57.4M +$65.9M May 1, 2023 Jul 31, 2023 10-K 2024-10-29
Q1 2023 -$45.6M -$15.2M -$10.3M -213% Feb 1, 2023 Apr 30, 2023 10-Q 2024-06-13
Q4 2022 -$35.2M -$11.3M -$8.67M -326% Nov 1, 2022 Jan 31, 2023 10-Q 2024-03-13
Q3 2022 -$26.6M -$10.6M -$8.32M -359% Aug 1, 2022 Oct 31, 2022 10-Q 2023-12-15
Q2 2022 -$18.3M -$8.43M -$11.7M -358% May 1, 2022 Jul 31, 2022 10-K 2023-11-03
Q1 2022 -$6.56M -$4.85M -$6.86M -342% Feb 1, 2022 Apr 30, 2022 10-Q 2023-06-14
Q4 2021 $300K -$2.66M -$4.96M -215% Nov 1, 2021 Jan 31, 2022 10-Q 2023-03-20
Q3 2021 $5.26M -$2.32M -$2.62M -876% Aug 1, 2021 Oct 31, 2021 10-Q 2022-12-12
Q2 2021 $7.88M $3.27M +$6.59M May 1, 2021 Jul 31, 2021 10-K 2022-10-14
Q1 2021 $1.28M $2.01M +$11.9M Feb 1, 2021 Apr 30, 2021 10-Q 2022-06-09
Q4 2020 -$10.6M $2.3M +$9.99M Nov 1, 2020 Jan 31, 2021 10-Q 2022-03-14
Q3 2020 -$20.6M $299K +$7.95M Aug 1, 2020 Oct 31, 2020 10-Q 2021-12-15
Q2 2020 -$28.6M -$3.33M +$2.07M +38.3% May 1, 2020 Jul 31, 2020 10-K 2020-10-19
Q1 2020 -$30.6M -$9.89M -$32.2M -144% Feb 1, 2020 Apr 30, 2020 10-Q 2021-06-11
Q4 2019 $1.54M -$7.69M +$721K +8.58% Nov 1, 2019 Jan 31, 2020 10-Q 2021-03-16
Q3 2019 $819K -$7.65M -$1.67M -27.9% Aug 1, 2019 Oct 31, 2019 10-Q 2020-12-11
Q2 2019 $2.49M -$5.39M +$368K +6.39% May 1, 2019 Jul 31, 2019 10-K 2020-10-19
Q1 2019 $2.12M $22.3M +$25.3M Feb 1, 2019 Apr 30, 2019 10-K 2020-10-19
Q4 2018 -$23.2M -$8.41M -$7.51M -833% Nov 1, 2018 Jan 31, 2019 10-K 2020-10-19
Q3 2018 -$15.7M -$5.98M -$5.34M -834% Aug 1, 2018 Oct 31, 2018 10-K 2020-10-19
Q2 2018 -$10.3M -$5.76M -$5.85M -6226% May 1, 2018 Jul 31, 2018 10-K 2019-10-15
Q1 2018 -$4.46M -$3.02M -$2.95M -4148% Feb 1, 2018 Apr 30, 2018 10-K 2019-10-15
Q4 2017 -$1.52M -$901K +$152K +14.4% Nov 1, 2017 Jan 31, 2018 10-K 2019-10-15
Q3 2017 -$1.67M -$640K +$834K +56.6% Aug 1, 2017 Oct 31, 2017 10-K 2019-10-15
Q2 2017 -$2.5M $94K -$36M -99.7% May 1, 2017 Jul 31, 2017 10-K 2018-10-15
Q1 2017 $33.5M -$71K +$2.04M +96.6% Feb 1, 2017 Apr 30, 2017 10-K 2018-10-15
Q4 2016 $31.5M -$1.05M -$7.89M -115% Nov 1, 2016 Jan 31, 2017 10-K 2018-10-15
Q3 2016 $39.4M -$1.47M -$5.91M -133% Aug 1, 2016 Oct 31, 2016 10-K 2018-10-15
Q2 2016 $45.3M $36.1M +$27.7M +328% May 1, 2016 Jul 31, 2016 10-K 2017-09-27
Q1 2016 $17.6M -$2.12M +$792K +27.2% Feb 1, 2016 Apr 30, 2016 10-K 2017-09-27
Q4 2015 $16.8M $6.83M +$10.9M Nov 1, 2015 Jan 31, 2016 10-K 2017-09-27
Q3 2015 $5.88M $4.43M +$8.16M Aug 1, 2015 Oct 31, 2015 10-K 2017-09-27
Q2 2015 -$2.29M $8.44M +$11.6M May 1, 2015 Jul 31, 2015 10-K 2016-10-13
Q1 2015 -$13.9M -$2.91M -$2.45M -539% Feb 1, 2015 Apr 30, 2015 10-K 2016-10-13
Q4 2014 -$11.4M -$4.09M -$525K -14.7% Nov 1, 2014 Jan 31, 2015 10-K 2016-10-13
Q3 2014 -$10.9M -$3.73M -$942K -33.8% Aug 1, 2014 Oct 31, 2014 10-K 2016-10-13
Q2 2014 -$9.98M -$3.17M -$67K -2.16% May 1, 2014 Jul 31, 2014 10-K 2015-10-13
Q1 2014 -$9.91M -$455K +$5.32M +92.1% Feb 1, 2014 Apr 30, 2014 10-K 2015-10-13
Q4 2013 -$15.2M -$3.57M +$2.11M +37.2% Nov 1, 2013 Jan 31, 2014 10-K 2015-10-13
Q3 2013 -$17.3M -$2.79M +$904K +24.5% Aug 1, 2013 Oct 31, 2013 10-K 2015-10-13
Q2 2013 -$18.2M -$3.1M +$24M +88.6% May 1, 2013 Jul 31, 2013 10-K 2014-10-09
Q1 2013 -$42.3M -$5.77M -$2.36M -69.2% Feb 1, 2013 Apr 30, 2013 10-K 2014-10-09
Q4 2012 -$39.9M -$5.67M -$1.45M -34.4% Nov 1, 2012 Jan 31, 2013 10-K 2014-10-09
Q3 2012 -$38.5M -$3.69M +$803K +17.9% Aug 1, 2012 Oct 31, 2012 10-K 2014-10-09
Q2 2012 -$39.3M -$27.1M -$23.1M -575% May 1, 2012 Jul 31, 2012 10-K 2013-10-15
Q1 2012 -$16.1M -$3.41M -$1.3M -61.7% Feb 1, 2012 Apr 30, 2012 10-K 2013-10-15
Q4 2011 -$14.8M -$4.22M +$1.49M +26.1% Nov 1, 2011 Jan 31, 2012 10-K 2013-10-15
Q3 2011 -$16.3M -$4.49M -$3.37M -301% Aug 1, 2011 Oct 31, 2011 10-K 2013-10-15
Q2 2011 -$13M -$4.02M May 1, 2011 Jul 31, 2011 10-K 2012-10-15
Q1 2011 -$2.11M Feb 1, 2011 Apr 30, 2011 10-K 2012-10-15
Q4 2010 -$5.71M Nov 1, 2010 Jan 31, 2011 10-K 2012-10-15
Q3 2010 -$1.12M Aug 1, 2010 Oct 31, 2010 10-K 2012-10-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.